Cargando…
Safety of Megestrol Acetate in Palliating Anorexia-Cachexia Syndrome in Patients with Castration-Resistant Prostate Cancer
There are concerns whether megestrol acetate (MA) stimulates the growth of prostate cancer in castration-resistant prostate cancer (CRPC). We evaluated the effect of cumulative doses of MA on the disease-specific survival (DSS) in patients with CRPC who were receiving Docetaxel-based chemotherapy. F...
Autores principales: | Hong, Sungwoo, Jeong, In Gab, You, Dalsan, Lee, Jae-Lyun, Hong, Jun Hyuk, Ahn, Hanjong, Kim, Choung-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653080/ https://www.ncbi.nlm.nih.gov/pubmed/23678259 http://dx.doi.org/10.3346/jkms.2013.28.5.687 |
Ejemplares similares
-
Megestrol acetate in cachexia and anorexia
por: Yeh, Shing-shing, et al.
Publicado: (2006) -
Megestrol acetate for cachexia–anorexia syndrome. A systematic review
por: Ruiz‐García, Vicente, et al.
Publicado: (2018) -
Prostate-specific antigen response rate of sequential chemotherapy in castration-resistant prostate cancer: the results of real life practice
por: Song, Geehyun, et al.
Publicado: (2013) -
Histologic Variability and Diverse Oncologic Outcomes of Prostate Sarcomas
por: Sohn, Mooyoung, et al.
Publicado: (2014) -
Prevalence and clinical significance of incidental (18)F-fluoro-2-deoxyglucose uptake in prostate
por: Kwon, Taekmin, et al.
Publicado: (2015)